MDD (also known as major depressive disorder) is characterised by prolonged and clinically significant symptoms of depression that are not clearly caused by another medical condition.[3] With a lifetime prevalence of 3–21%,[1][4][5] the various sub-types of MDD are associated with significant morbidity, disability and mortality,[1][2][6] including an increased risk of suicide.[7] The wider societal impact of MDD is also considerable,[8] with a reduced ability to work and be productive.[9] Therapeutic approaches include pharmacological and non-pharmacological treatments, although up to 3 in 10 patients fail to respond to treatment and are considered treatment resistant (fail to respond to two or more antidepressants during a single episode of major depression).[10]
Country | Lifetime Prevalence (%) |
---|---|
Country Belgium | Lifetime Prevalence (%) 14.1 ± 1.0 |
Country France | Lifetime Prevalence (%) 21.0 ± 1.1 |
Country Germany | Lifetime Prevalence (%) 9.9 ± 0.6 |
Country Italy | Lifetime Prevalence (%) 9.9 ± 0.5 |
Country Netherlands | Lifetime Prevalence (%) 17.9 ± 1.0 |
Country Spain | Lifetime Prevalence (%) 10.6 ± 0.6 |
The symptoms of major depression impair an individual's ability to perform normal daily functions at home and at work.[3] Symptoms include:
Plus, suicide risk is significantly elevated among patients with major depression.[3]
Note: these data refer to a mixed population of both patients and carers – separate data for each group was not made available
Depressive disorders are classified according to the 2013 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)[3] or the International Classification of Diseases, 10th Revision (ICD-10) classification of mental and behavioural disorders.[13] An update to the ICD has been developed (ICD-11), but global uptake and implementation is still underway.[14]
MDD often follows a chronic course, first conceptualised in 1991 by the MacArthur Foundation Research Network on the Psychobiology of Depression task force.[15] On average, a patient faces just under 4 lifetime episodes, with the longest episode lasting 26 weeks.[16]
Key stage | Definition | Timeframe |
---|---|---|
Key stage MDD episode | Definition Symptoms meet DSM-5 / ICD-10 criteria | Timeframe ≥ 2 weeks |
Key stage | Definition HAMD-17 ≤ 4 | Timeframe |
Key stage | Definition A new period of MDD symptoms | Timeframe |
The COVID-19 pandemic has caused a decline in mental wellbeing among all age groups in Europe, especially among those who have lost their jobs.[26]
Note: Based on WHO-5 mental well-being index. People with a WHO-5 score of 50 or lower are considered to be at risk of depression
Chart adapted from Eurofound[26]
WHO reports that mental health is a leading cause of disability worldwide.[27]
Plus, patients with depression are more than 1.5 times likely to develop ischaemic heart disease than the general population.[31]
Subtypes of MDD include postpartum and antepartum depression, psychotic depression and seasonal affective disorder.[3]
Patients with other mental health conditions may also experience depressive symptoms but do not necessarily fall within the classification of major depression. For example, patients with bipolar disorder will present with symptoms of depression, but they are differentiated from MDD due to the presence of manic, hypomanic, or mixed episodes[13]
ACNP, American College of Neuropsychiatry. DSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. ED, Emergency department. ER, Emergency room. HAMD-17, Hamilton Depression Rating Scale. ICD-10, International Classification for Diseases, 10th Revision. MDD, Major depressive disorder. SAD, Seasonal affective disorder.